{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:03:25Z","timestamp":1781759005039,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H06402"],"award-info":[{"award-number":["JP16H06402"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Changes in \u03b3-aminobutyric acid (GABA) function are noted in patients with Parkinson's disease (PD) who have some non-motor impairments. However, dopamine-related GABA function and GABA-related cognitive changes are still unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Thirteen drug-naive early-stage PD patients underwent a series of PET scans with [<jats:sup>11<\/jats:sup>C]flumazenil(FMZ) and [<jats:sup>11<\/jats:sup>C]CFT. The [<jats:sup>11<\/jats:sup>C]FMZ binding potential (BP<jats:sub>ND<\/jats:sub>) derived from a Logan plot analysis was compared between PD patients and age-matched controls. The [<jats:sup>11<\/jats:sup>C]CFT radioactivity relative to the cerebellar counterpart was estimated as a semiquantitative value [<jats:sup>11<\/jats:sup>C]CFT SUVR. Correlations between [<jats:sup>11<\/jats:sup>C]FMZ BP<jats:sub>ND<\/jats:sub> and [<jats:sup>11<\/jats:sup>C]CFT SUVR in the same region of interest were also examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In patients in the PD group, [<jats:sup>11<\/jats:sup>C]CFT SUVR was significantly lower in the putamen. The levels of [<jats:sup>11<\/jats:sup>C]FMZ BP<jats:sub>ND<\/jats:sub> in the cerebral cortex (frontal lobe dominancy) and the affected-side putamen were also reduced. In addition, [<jats:sup>11<\/jats:sup>C]CFT SUVR was negatively correlated with the [<jats:sup>11<\/jats:sup>C]FMZ BP<jats:sub>ND<\/jats:sub> level in the affected-side putamen. In patients in the PD group, the total frontal assessment battery (FAB) score was positively correlated with the [<jats:sup>11<\/jats:sup>C]FMZ BP<jats:sub>ND<\/jats:sub> in the frontal region.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>GABAergic dysfunction coexists with dopaminergic loss not only in the putamen but also over the extrastriatal region in patients with early PD and is related to frontal dysfunction. The negative correlation of [<jats:sup>11<\/jats:sup>C]CFT SUVR with [<jats:sup>11<\/jats:sup>C]FMZ BP<jats:sub>ND<\/jats:sub> in the affected putamen suggests that a greater dopaminergic demise would decelerate GABA release (or an increase in tracer binding), resulting in persistent failure of the GABAergic system in PD patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.880407","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T04:30:17Z","timestamp":1652761817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["In vivo Illustration of Altered Dopaminergic and GABAergic Systems in Early Parkinson's Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Hirotsugu","family":"Takashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Bunai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Obi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuomi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1093\/brain\/114.5.2095","article-title":"Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability","volume":"114","author":"Cooper","year":"1991","journal-title":"Brain."},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis","volume":"11","author":"Kehagia","year":"2013","journal-title":"Neurodegener Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1254\/jjp.48.331","article-title":"GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease","volume":"48","author":"Nishino","year":"1988","journal-title":"Jpn J Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e30918","DOI":"10.1371\/journal.pone.0030918","article-title":"Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS","volume":"7","author":"Emir","year":"2012","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hbm.24857","article-title":"GABAergic changes in the thalamocortical circuit in Parkinson's disease","volume":"41","author":"van Nuland","year":"2020","journal-title":"Hum Brain Mapp."},{"key":"B7","doi-asserted-by":"publisher","first-page":"104979","DOI":"10.1016\/j.nbd.2020.104979","article-title":"GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming","volume":"143","author":"Nishijima","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnins.2016.00269","article-title":"Parkinson's disease and neurodegeneration: GABA-collapse hypothesis","volume":"10","author":"Blaszczyk","year":"2016","journal-title":"Front Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1093\/brain\/awaa305","article-title":"GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition","volume":"143","author":"Murley","year":"2020","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/jmri.24665","article-title":"Decreased gamma-aminobutyric acid levels in the parietal region of patients with Alzheimer's disease","volume":"41","author":"Bai","year":"2015","journal-title":"J Magn Reson Imaging."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1212\/WNL.0000000000006007","article-title":"Reduced occipital GABA in Parkinson disease with visual hallucinations","volume":"91","author":"Firbank","year":"2018","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bpa.12511","article-title":"Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies","volume":"28","author":"Santpere","year":"2018","journal-title":"Brain Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1523\/JNEUROSCI.2028-18.2018","article-title":"Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB receptors","volume":"39","author":"Lopes","year":"2019","journal-title":"J Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1212\/WNL.51.1.136","article-title":"Altered glucose metabolism in the hippocampal head in memory impairment","volume":"51","author":"Ouchi","year":"1998","journal-title":"Neurology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/1531-8249(199905)45:5<601::AID-ANA8>3.0.CO;2-0","article-title":"Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography","volume":"45","author":"Ouchi","year":"1999","journal-title":"Ann Neurol."},{"key":"B17","volume-title":"Atlas of the Human Brain","author":"Mai","year":"1997"},{"key":"B18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1109\/TNS.2002.1039541","article-title":"A new high-resolution PET scanner dedicated to brain research","volume":"49","author":"Watanabe","year":"2002","journal-title":"IEEE Trans Nucl Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","article-title":"Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency","volume":"73","author":"Pearl","year":"2009","journal-title":"Neurology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/jcbfm.1995.34","article-title":"Quantification of benzodiazepine receptors in human brain using PET,[11C] flumazenil, and a single-experiment protocol","volume":"15","author":"Delforge","year":"1995","journal-title":"J Cereb Blood Flow Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12149-011-0480-4","article-title":"Validation of reference tissue modelling for[11C]flumazenil positron emission tomography following head injury","volume":"25","author":"Geeraerts","year":"2011","journal-title":"Ann Nucl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00259-008-0990-z","article-title":"Kinetic modelling of[11C]flumazenil using data-driven methods","volume":"36","author":"Miederer","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuroimage.2008.02.035","article-title":"Measurement of GABAA receptor binding in vivo with[11C]flumazenil: a test-retest study in healthy subjects","volume":"41","author":"Salmi","year":"2008","journal-title":"Neuroimage."},{"key":"B24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging."},{"key":"B25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neurobiolaging.2013.08.018","article-title":"Reduced functional connectivity in early-stage drug-naive Parkinson's disease: a resting-state fMRI study","volume":"35","author":"Luo","year":"2014","journal-title":"Neurobiol Aging."},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrn3155","article-title":"Interneuron dysfunction in psychiatric disorders","volume":"13","author":"Marin","year":"2012","journal-title":"Nat Rev Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/WNN.0b013e3182350a1f","article-title":"Brief cognitive assessment in the early stages of Parkinson disease","volume":"24","author":"Bugalho","year":"2011","journal-title":"Cogn Behav Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990","journal-title":"Trends Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fnins.2019.00299","article-title":"Quantitative research of (11)C-CFT and (18)F-FDG PET in Parkinson's disease: a pilot study with NeuroQ software","volume":"13","author":"Sun","year":"2019","journal-title":"Front Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/ane.12365","article-title":"Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study","volume":"131","author":"Pellecchia","year":"2015","journal-title":"Acta Neurol Scand."},{"key":"B33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fnagi.2018.00412","article-title":"Usefulness differs between the visual assessment and specific binding ratio of (123)I-ioflupane SPECT in assessing clinical symptoms of drug-naive Parkinson's disease patients","volume":"10","author":"Murakami","year":"2018","journal-title":"Front Aging Neurosci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.880407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T04:30:23Z","timestamp":1652761823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.880407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":33,"alternative-id":["10.3389\/fneur.2022.880407"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.880407","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"article-number":"880407"}}